Assessing Market Sentiment on MNST

This morning we watched Monster Beverage drop -1.3% to a price of $55.06 per share. The large-cap Beverages company is now trading -11.45% below its average target price of $62.18. Analysts have set target prices ranging from $51.5 to $72.0 per share for Monster Beverage, and have given the stock an average rating of buy.

Monster Beverage's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.7%. The stock's short ratio is 2.74. The company's insiders own 28.07% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 68.1%. In conclusion, we believe there is positive market sentiment regarding Monster Beverage.

Institutions Invested in Monster Beverage

Date Reported Holder Percentage Shares Value
2023-06-30 Vanguard Group Inc 6% 63,491,955 $3,495,867,129
2023-06-30 Blackrock Inc. 5% 53,324,053 $2,936,022,431
2023-06-30 FMR, LLC 4% 39,453,041 $2,172,284,491
2023-06-30 Alliancebernstein L.P. 4% 37,174,265 $2,046,815,081
2023-06-30 State Street Corporation 3% 34,684,521 $1,909,729,773
2023-06-30 JP Morgan Chase & Company 3% 29,760,640 $1,638,620,879
2023-06-30 Loomis Sayles & Company, LP 3% 27,203,495 $1,497,824,472
2023-06-30 Capital World Investors 2% 21,587,295 $1,188,596,492
2023-06-30 Nuveen Asset Management, LLC 2% 18,321,200 $1,008,765,297
2023-06-30 Price (T.Rowe) Associates Inc 2% 17,638,324 $971,166,143
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS